Work

104 EVERLAST-A: A Phase 2a Study Design of ORKA-001, a Novel Half-Life Extended IL-23p19 Monoclonal Antibody for Plaque Psoriasis

Year: 2025

Type: article

Source: Journal of Investigative Dermatology

DOI: 10.1016/j.jid.2025.09.122

Authors: Andrew Blauvelt, Bruce Strober, Joseph Merola, James Krueger, Joel Gelfand, Johann Gudjonsson, Eugenia Levi, Joana Goncalves, Mark Lebwohl

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4416083762

FWCI:

Cites:

Cited by:

Related to: 10